首页 > 最新文献

JMIR Diabetes最新文献

英文 中文
Agreement Between AI and Nephrologists in Addressing Common Patient Questions About Diabetic Nephropathy: Cross-Sectional Study. AI与肾病专家在解决糖尿病肾病常见问题上的共识:横断面研究。
Q2 Medicine Pub Date : 2025-05-02 DOI: 10.2196/65846
Niloufar Ebrahimi, Mehrbod Vakhshoori, Seigmund Teichman, Amir Abdipour

Unlabelled: This research letter presents a cross-sectional analysis comparing the agreement between artificial intelligence models and nephrologists in responding to common patient questions about diabetic nephropathy.

未标记:这封研究信函提出了一项横断面分析,比较了人工智能模型和肾病学家在回答糖尿病肾病常见患者问题时的一致性。
{"title":"Agreement Between AI and Nephrologists in Addressing Common Patient Questions About Diabetic Nephropathy: Cross-Sectional Study.","authors":"Niloufar Ebrahimi, Mehrbod Vakhshoori, Seigmund Teichman, Amir Abdipour","doi":"10.2196/65846","DOIUrl":"https://doi.org/10.2196/65846","url":null,"abstract":"<p><strong>Unlabelled: </strong>This research letter presents a cross-sectional analysis comparing the agreement between artificial intelligence models and nephrologists in responding to common patient questions about diabetic nephropathy.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e65846"},"PeriodicalIF":0.0,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12064210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
mHealth Social Support Versus Standard Support for Diabetes Management in Safety-Net Emergency Department Patients: Randomized Phase-III Trial. 安全网络急诊科患者糖尿病管理的移动健康社会支持与标准支持:随机iii期试验
Q2 Medicine Pub Date : 2025-04-23 DOI: 10.2196/56934
Elizabeth Burner, Danielle Hazime, Michael Menchine, Wendy Mack, Janisse Mercado, Adriana Aleman, Antonio Hernandez Saenz, Sanjay Arora, Shinyi Wu
<p><strong>Background: </strong>Mobile health (mHealth) is a low-cost method to improve health for patients with diabetes seeking care in safety-net emergency departments, resulting in improved medication adherence and self-management. Additions of social support to mHealth interventions could further enhance diabetes self-management by increasing the gains and the postintervention maintenance.</p><p><strong>Objective: </strong>We assessed outcomes of an unblinded, parallel, equal-allocation randomized phase-III trial that tested a social support mHealth intervention to improve emergency department patients' diabetes self-management.</p><p><strong>Methods: </strong>Patients with glycated hemoglobin (HbA<sub>1c</sub>) levels of ≥8.5% mg/dL and a text-capable phone were recruited during their emergency department visit for any reason (diabetes related or not) at a US public hospital along with a friend or family member as a supporter. Patients received 6 months of the Trial to Examine Text Messaging in Emergency Department Patients With Diabetes self-management mHealth program. Supporters were randomized to receive either (1) an mHealth social support program (Family and Friends Network Support)-daily SMS text messages guiding supporters to provide diabetes-related social support-or (2) a non-mHealth social support program as an active control-pamphlet-augmented social support with Family and Friends Network Support content. Point-of-care HbA<sub>1c</sub> level, self-reported diabetes self-care activities, medication adherence, and safety events were collected. Mixed-effects linear regression models analyzed group differences at the end of the intervention (6 months) and the postintervention phase (12 months) for HbA<sub>1c</sub> level and behavioral outcomes.</p><p><strong>Results: </strong>A total of 166 patients were randomized. In total, 8.4% (n=14) reported type 1 diabetes, 66.9% (n=111) reported type 2 diabetes, and 24.7% (n=41) did not know their diabetes type; 50% (n=83) reported using insulin for diabetes management. Trial follow-up was completed with 58.4% (n=97) of the patients at 6 months and 63.9% (n=106) of the patients at 12 months. Both groups showed significant HbA<sub>1c</sub> level improvements (combined group change=1.36%, SD 2.42% mg/dL; 95% CI 0.87-1.83; P<.001), with no group difference (group mean difference=0.14%, SD 4.88% mg/dL; 95% CI -1.11 to 0.83; P=.87) at 6 months. At 12 months, both groups maintained their improved HbA<sub>1c</sub> levels, with a combined mean change from 6 months of 0.06% (SD 1.89% mg/dL; 95% CI -0.34 to 0.47; P=.76) and no clinically meaningful difference between groups. No differences were observed in safety events. In subgroup analyses, patients recently diagnosed with diabetes in the mHealth social support group improved their glycemic control compared to the standard social support group (between-group difference of 1.96%, SD 9.59% mg/dL; 95% CI -3.81 to -0.125; P=.04).</p><p><strong>Conclusion
背景:移动医疗(mHealth)是一种低成本的方法,可以改善在安全网急诊科寻求治疗的糖尿病患者的健康状况,从而改善药物依从性和自我管理。在移动医疗干预措施中增加社会支持可以通过增加收益和干预后维持来进一步加强糖尿病自我管理。目的:我们评估了一项非盲、平行、均等分配的随机iii期试验的结果,该试验测试了社会支持移动健康干预来改善急诊科患者的糖尿病自我管理。方法:招募糖化血红蛋白(HbA1c)水平≥8.5% mg/dL的患者,在任何原因(糖尿病相关或非糖尿病相关)的美国公立医院急诊科就诊期间,由朋友或家人作为支持者。患者接受了6个月的试验,以检查急诊科糖尿病患者自我管理移动健康项目中的短信。支持者被随机分配接受(1)移动健康社会支持计划(家庭和朋友网络支持)-每天发送短信指导支持者提供与糖尿病相关的社会支持;或(2)非移动健康社会支持计划作为积极控制-小册子-增强社会支持与家庭和朋友网络支持内容。收集护理点HbA1c水平、自我报告的糖尿病自我护理活动、药物依从性和安全事件。混合效应线性回归模型分析干预结束(6个月)和干预后阶段(12个月)各组HbA1c水平和行为结果的差异。结果:共纳入166例患者。总共有8.4% (n=14)报告为1型糖尿病,66.9% (n=111)报告为2型糖尿病,24.7% (n=41)不知道自己的糖尿病类型;50% (n=83)报告使用胰岛素治疗糖尿病。6个月时58.4% (n=97)的患者完成了试验随访,12个月时63.9% (n=106)的患者完成了试验随访。两组HbA1c水平均有显著改善(联合组变化1.36%,SD变化2.42% mg/dL;95% ci 0.87-1.83;P1c水平,6个月的综合平均变化为0.06% (SD 1.89% mg/dL;95% CI -0.34 ~ 0.47;P= 0.76),两组间无临床意义差异。在安全事件方面没有观察到差异。在亚组分析中,与标准社会支持组相比,移动健康社会支持组中最近诊断为糖尿病的患者血糖控制得到改善(组间差异为1.96%,SD为9.59% mg/dL;95% CI -3.81 ~ -0.125;P = .04点)。结论:在使用现有的以患者为中心的移动健康糖尿病自我管理项目的人群中,HbA1c水平的6个月变化并没有因社会支持模式而不同,但两组患者的自我管理和血糖控制都有所改善。新诊断的糖尿病患者从移动医疗增强的社会支持中获益最多。试验注册:ClinicalTrials.gov NCT03178773;https://clinicaltrials.gov/study/NCT03178773.International注册报告标识符(irrid): RR2-10.1016/j.c cct.2019.03.003。
{"title":"mHealth Social Support Versus Standard Support for Diabetes Management in Safety-Net Emergency Department Patients: Randomized Phase-III Trial.","authors":"Elizabeth Burner, Danielle Hazime, Michael Menchine, Wendy Mack, Janisse Mercado, Adriana Aleman, Antonio Hernandez Saenz, Sanjay Arora, Shinyi Wu","doi":"10.2196/56934","DOIUrl":"https://doi.org/10.2196/56934","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Mobile health (mHealth) is a low-cost method to improve health for patients with diabetes seeking care in safety-net emergency departments, resulting in improved medication adherence and self-management. Additions of social support to mHealth interventions could further enhance diabetes self-management by increasing the gains and the postintervention maintenance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;We assessed outcomes of an unblinded, parallel, equal-allocation randomized phase-III trial that tested a social support mHealth intervention to improve emergency department patients' diabetes self-management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients with glycated hemoglobin (HbA&lt;sub&gt;1c&lt;/sub&gt;) levels of ≥8.5% mg/dL and a text-capable phone were recruited during their emergency department visit for any reason (diabetes related or not) at a US public hospital along with a friend or family member as a supporter. Patients received 6 months of the Trial to Examine Text Messaging in Emergency Department Patients With Diabetes self-management mHealth program. Supporters were randomized to receive either (1) an mHealth social support program (Family and Friends Network Support)-daily SMS text messages guiding supporters to provide diabetes-related social support-or (2) a non-mHealth social support program as an active control-pamphlet-augmented social support with Family and Friends Network Support content. Point-of-care HbA&lt;sub&gt;1c&lt;/sub&gt; level, self-reported diabetes self-care activities, medication adherence, and safety events were collected. Mixed-effects linear regression models analyzed group differences at the end of the intervention (6 months) and the postintervention phase (12 months) for HbA&lt;sub&gt;1c&lt;/sub&gt; level and behavioral outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 166 patients were randomized. In total, 8.4% (n=14) reported type 1 diabetes, 66.9% (n=111) reported type 2 diabetes, and 24.7% (n=41) did not know their diabetes type; 50% (n=83) reported using insulin for diabetes management. Trial follow-up was completed with 58.4% (n=97) of the patients at 6 months and 63.9% (n=106) of the patients at 12 months. Both groups showed significant HbA&lt;sub&gt;1c&lt;/sub&gt; level improvements (combined group change=1.36%, SD 2.42% mg/dL; 95% CI 0.87-1.83; P&lt;.001), with no group difference (group mean difference=0.14%, SD 4.88% mg/dL; 95% CI -1.11 to 0.83; P=.87) at 6 months. At 12 months, both groups maintained their improved HbA&lt;sub&gt;1c&lt;/sub&gt; levels, with a combined mean change from 6 months of 0.06% (SD 1.89% mg/dL; 95% CI -0.34 to 0.47; P=.76) and no clinically meaningful difference between groups. No differences were observed in safety events. In subgroup analyses, patients recently diagnosed with diabetes in the mHealth social support group improved their glycemic control compared to the standard social support group (between-group difference of 1.96%, SD 9.59% mg/dL; 95% CI -3.81 to -0.125; P=.04).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e56934"},"PeriodicalIF":0.0,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Psychosocial Burdens of Diabetes in Pregnancy and the Feasibility of Technology-Based Support: Qualitative Study. 探讨妊娠期糖尿病的社会心理负担和技术支持的可行性:定性研究。
Q2 Medicine Pub Date : 2025-04-21 DOI: 10.2196/53854
Maya V Roytman, Layna Lu, Elizabeth Soyemi, Karolina Leziak, Charlotte M Niznik, Lynn M Yee
<p><strong>Background: </strong>Gestational diabetes mellitus and type 2 diabetes mellitus impose psychosocial burdens on pregnant individuals. As there is less evidence about the experience and management of psychosocial burdens of diabetes mellitus during pregnancy, we sought to identify these psychosocial burdens and understand how a novel smartphone app may alleviate them. The app was designed to provide supportive, educational, motivational, and logistical support content, delivered through interactive messages.</p><p><strong>Objective: </strong>The study aimed to analyze the qualitative data generated in a feasibility randomized controlled trial of a novel mobile app designed to promote self-management skills, motivate healthy behaviors, and inform low-income pregnant individuals with diabetes.</p><p><strong>Methods: </strong>Individuals receiving routine clinical care at a single, large academic medical center in Chicago, Illinois were randomized to use of the SweetMama app (n=30) or usual care (n=10) from diagnosis of diabetes until 6 weeks post partum. All individuals completed exit interviews at delivery about their experience of having diabetes during pregnancy. Interviews were guided by a semistructured interview guide and were conducted by a single interviewer extensively trained in empathic, culturally sensitive qualitative interviewing of pregnant and postpartum people. SweetMama users were also queried about their perspectives on the app. Interview data were audio-recorded and professionally transcribed. Data were analyzed by 2 researchers independently using grounded theory constant comparative techniques.</p><p><strong>Results: </strong>Of the 40 participants, the majority had gestational diabetes mellitus (n=25, 63%), publicly funded prenatal care (n=33, 83%), and identified as non-Hispanic Black (n=25, 63%) or Hispanic (n=14, 35%). Participants identified multiple psychosocial burdens, including challenges taking action, negative affectivity regarding diagnosis, diet guilt, difficulties managing other responsibilities, and reluctance to use insulin. External factors, such as taking care of children or navigating the COVID-19 pandemic, affected participant self-perception and motivation to adhere to clinical recommendations. SweetMama participants largely agreed that the use of the app helped mitigate these burdens by enhancing self-efficacy, capitalizing on external motivation, validating efforts, maintaining medical nutrition therapy, extending clinical care, and building a sense of community. Participants expressed that SweetMama supported the goals they established with their clinical team and helped them harness motivating factors for self-care.</p><p><strong>Conclusions: </strong>Psychosocial burdens of diabetes during pregnancy present challenges with diabetes self-management. Mobile health support may be an effective tool to provide motivation, behavioral cues, and access to educational and social network resources to a
背景:妊娠期糖尿病和2型糖尿病对妊娠个体造成社会心理负担。由于关于怀孕期间糖尿病的心理社会负担的经验和管理的证据较少,我们试图确定这些心理社会负担,并了解一款新的智能手机应用程序如何减轻这些负担。该应用程序旨在通过互动信息提供支持性、教育性、激励性和后勤支持内容。目的:本研究旨在分析一种新型移动应用程序的可行性随机对照试验产生的定性数据,该应用程序旨在提高自我管理技能,激励健康行为,并告知低收入糖尿病孕妇。方法:在伊利诺伊州芝加哥的一个大型学术医疗中心接受常规临床护理的个体,从诊断为糖尿病到产后6周,随机分为使用sweetama应用程序(n=30)或常规护理(n=10)。所有个体在分娩时都完成了关于怀孕期间患糖尿病经历的退出访谈。访谈由半结构化访谈指南指导,并由一位接受过广泛的移情、文化敏感的孕妇和产后定性访谈培训的采访者进行。SweetMama的用户也被询问了他们对这款应用的看法。采访数据被录音并专业转录。数据由两名研究人员独立分析,采用扎根理论常数比较技术。结果:在40名参与者中,大多数患有妊娠糖尿病(n=25, 63%),公共资助的产前护理(n=33, 83%),并确定为非西班牙裔黑人(n=25, 63%)或西班牙裔(n=14, 35%)。参与者确定了多重社会心理负担,包括采取行动的挑战、对诊断的负面情绪、饮食内疚、管理其他责任的困难以及不愿使用胰岛素。照顾儿童或应对COVID-19大流行等外部因素影响了参与者的自我认知和遵守临床建议的动机。sweetama的参与者基本上同意,通过提高自我效能、利用外部动机、验证努力、维持医疗营养治疗、延长临床护理和建立社区意识,使用这款应用有助于减轻这些负担。参与者表示,sweetama支持他们与临床团队建立的目标,并帮助他们利用自我保健的激励因素。结论:妊娠期糖尿病的社会心理负担对糖尿病自我管理提出了挑战。移动卫生支持可能是一种有效的工具,可以提供动机、行为线索以及获得教育和社会网络资源,以减轻怀孕期间的社会心理负担。未来在应用程序中加入机器学习和语言处理模型,可能会为妊娠期糖尿病患者提供进一步个性化的建议和教育。试验注册:ClinicalTrials.gov NCT03240874;https://clinicaltrials.gov/study/NCT03240874。
{"title":"Exploring Psychosocial Burdens of Diabetes in Pregnancy and the Feasibility of Technology-Based Support: Qualitative Study.","authors":"Maya V Roytman, Layna Lu, Elizabeth Soyemi, Karolina Leziak, Charlotte M Niznik, Lynn M Yee","doi":"10.2196/53854","DOIUrl":"https://doi.org/10.2196/53854","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Gestational diabetes mellitus and type 2 diabetes mellitus impose psychosocial burdens on pregnant individuals. As there is less evidence about the experience and management of psychosocial burdens of diabetes mellitus during pregnancy, we sought to identify these psychosocial burdens and understand how a novel smartphone app may alleviate them. The app was designed to provide supportive, educational, motivational, and logistical support content, delivered through interactive messages.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The study aimed to analyze the qualitative data generated in a feasibility randomized controlled trial of a novel mobile app designed to promote self-management skills, motivate healthy behaviors, and inform low-income pregnant individuals with diabetes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Individuals receiving routine clinical care at a single, large academic medical center in Chicago, Illinois were randomized to use of the SweetMama app (n=30) or usual care (n=10) from diagnosis of diabetes until 6 weeks post partum. All individuals completed exit interviews at delivery about their experience of having diabetes during pregnancy. Interviews were guided by a semistructured interview guide and were conducted by a single interviewer extensively trained in empathic, culturally sensitive qualitative interviewing of pregnant and postpartum people. SweetMama users were also queried about their perspectives on the app. Interview data were audio-recorded and professionally transcribed. Data were analyzed by 2 researchers independently using grounded theory constant comparative techniques.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 40 participants, the majority had gestational diabetes mellitus (n=25, 63%), publicly funded prenatal care (n=33, 83%), and identified as non-Hispanic Black (n=25, 63%) or Hispanic (n=14, 35%). Participants identified multiple psychosocial burdens, including challenges taking action, negative affectivity regarding diagnosis, diet guilt, difficulties managing other responsibilities, and reluctance to use insulin. External factors, such as taking care of children or navigating the COVID-19 pandemic, affected participant self-perception and motivation to adhere to clinical recommendations. SweetMama participants largely agreed that the use of the app helped mitigate these burdens by enhancing self-efficacy, capitalizing on external motivation, validating efforts, maintaining medical nutrition therapy, extending clinical care, and building a sense of community. Participants expressed that SweetMama supported the goals they established with their clinical team and helped them harness motivating factors for self-care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Psychosocial burdens of diabetes during pregnancy present challenges with diabetes self-management. Mobile health support may be an effective tool to provide motivation, behavioral cues, and access to educational and social network resources to a","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e53854"},"PeriodicalIF":0.0,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12053129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Toward Personalized Digital Experiences to Promote Diabetes Self-Management: Mixed Methods Social Computing Approach. 更正:迈向个性化数字体验以促进糖尿病自我管理:混合方法和社会计算方法。
Q2 Medicine Pub Date : 2025-04-18 DOI: 10.2196/75497
Tavleen Singh, Kirk Roberts, Kayo Fujimoto, Jing Wang, Constance Johnson, Sahiti Myneni
{"title":"Correction: Toward Personalized Digital Experiences to Promote Diabetes Self-Management: Mixed Methods Social Computing Approach.","authors":"Tavleen Singh, Kirk Roberts, Kayo Fujimoto, Jing Wang, Constance Johnson, Sahiti Myneni","doi":"10.2196/75497","DOIUrl":"10.2196/75497","url":null,"abstract":"","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e75497"},"PeriodicalIF":0.0,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12026174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Detection of Elevated Ketone Bodies in Type 1 Diabetes Using Insulin and Glucose Dynamics Across Age Groups: Model Development Study. 使用胰岛素和葡萄糖动态在1型糖尿病中早期检测酮体升高:模型开发研究。
Q2 Medicine Pub Date : 2025-04-10 DOI: 10.2196/67867
Simon Cichosz, Clara Bender

Background: Diabetic ketoacidosis represents a significant and potentially life-threatening complication of diabetes, predominantly observed in individuals with type 1 diabetes (T1D). Studies have documented suboptimal adherence to diabetes management among children and adolescents, as evidenced by deficient ketone monitoring practices.

Objective: The aim of the study was to explore the potential for prediction of elevated ketone bodies from continuous glucose monitoring (CGM) and insulin data in pediatric and adult patients with T1D using a closed-loop system.

Methods: Participants used the Dexcom G6 CGM system and the iLet Bionic Pancreas system for insulin administration for up to 13 weeks. We used supervised binary classification machine learning, incorporating feature engineering to identify elevated ketone bodies (>0.6 mmol/L). Features were derived from CGM, insulin delivery data, and self-monitoring of blood glucose to develop an extreme gradient boosting-based prediction model. A total of 259 participants aged 6-79 years with over 49,000 days of full-time monitoring were included in the study.

Results: Among the participants, 1768 ketone samples were eligible for modeling, including 383 event samples with elevated ketone bodies (≥0.6 mmol/L). Insulin, self-monitoring of blood glucose, and current glucose measurements provided discriminative information on elevated ketone bodies (receiver operating characteristic area under the curve [ROC-AUC] 0.64-0.69). The CGM-derived features exhibited stronger discrimination (ROC-AUC 0.75-0.76). Integration of all feature types resulted in an ROC-AUC estimate of 0.82 (SD 0.01) and a precision recall-AUC of 0.53 (SD 0.03).

Conclusions: CGM and insulin data present a valuable avenue for early prediction of patients at risk of elevated ketone bodies. Furthermore, our findings indicate the potential application of such predictive models in both pediatric and adult populations with T1D.

背景:糖尿病酮症酸中毒是一种重要且可能危及生命的糖尿病并发症,主要见于1型糖尿病(T1D)患者。研究表明,儿童和青少年对糖尿病管理的依从性不佳,缺乏酮监测实践证明了这一点。目的:本研究的目的是探讨使用闭环系统从儿童和成人T1D患者的连续血糖监测(CGM)和胰岛素数据中预测酮体升高的潜力。方法:参与者使用Dexcom G6 CGM系统和iLet仿生胰腺系统进行长达13周的胰岛素给药。我们使用监督二分类机器学习,结合特征工程来识别升高的酮体(>0.6 mmol/L)。特征来源于CGM、胰岛素输送数据和自我血糖监测,以建立一个基于极端梯度增强的预测模型。共有259名年龄在6-79岁之间的参与者参与了这项研究,他们接受了超过49,000天的全天候监测。结果:在参与者中,1768个酮类样本符合建模条件,其中383个事件样本酮体升高(≥0.6 mmol/L)。胰岛素、自我血糖监测和当前血糖测量提供了酮体升高的判别信息(受试者曲线下工作特征面积[ROC-AUC] 0.64-0.69)。cgm衍生特征具有较强的辨别能力(ROC-AUC 0.75 ~ 0.76)。所有特征类型的整合导致ROC-AUC估计为0.82 (SD 0.01),精确recall-AUC为0.53 (SD 0.03)。结论:CGM和胰岛素数据为早期预测有酮体升高风险的患者提供了有价值的途径。此外,我们的研究结果表明这种预测模型在儿童和成人T1D患者中的潜在应用。
{"title":"Early Detection of Elevated Ketone Bodies in Type 1 Diabetes Using Insulin and Glucose Dynamics Across Age Groups: Model Development Study.","authors":"Simon Cichosz, Clara Bender","doi":"10.2196/67867","DOIUrl":"https://doi.org/10.2196/67867","url":null,"abstract":"<p><strong>Background: </strong>Diabetic ketoacidosis represents a significant and potentially life-threatening complication of diabetes, predominantly observed in individuals with type 1 diabetes (T1D). Studies have documented suboptimal adherence to diabetes management among children and adolescents, as evidenced by deficient ketone monitoring practices.</p><p><strong>Objective: </strong>The aim of the study was to explore the potential for prediction of elevated ketone bodies from continuous glucose monitoring (CGM) and insulin data in pediatric and adult patients with T1D using a closed-loop system.</p><p><strong>Methods: </strong>Participants used the Dexcom G6 CGM system and the iLet Bionic Pancreas system for insulin administration for up to 13 weeks. We used supervised binary classification machine learning, incorporating feature engineering to identify elevated ketone bodies (>0.6 mmol/L). Features were derived from CGM, insulin delivery data, and self-monitoring of blood glucose to develop an extreme gradient boosting-based prediction model. A total of 259 participants aged 6-79 years with over 49,000 days of full-time monitoring were included in the study.</p><p><strong>Results: </strong>Among the participants, 1768 ketone samples were eligible for modeling, including 383 event samples with elevated ketone bodies (≥0.6 mmol/L). Insulin, self-monitoring of blood glucose, and current glucose measurements provided discriminative information on elevated ketone bodies (receiver operating characteristic area under the curve [ROC-AUC] 0.64-0.69). The CGM-derived features exhibited stronger discrimination (ROC-AUC 0.75-0.76). Integration of all feature types resulted in an ROC-AUC estimate of 0.82 (SD 0.01) and a precision recall-AUC of 0.53 (SD 0.03).</p><p><strong>Conclusions: </strong>CGM and insulin data present a valuable avenue for early prediction of patients at risk of elevated ketone bodies. Furthermore, our findings indicate the potential application of such predictive models in both pediatric and adult populations with T1D.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e67867"},"PeriodicalIF":0.0,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12005466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Decision Support for Perioperative Care of Patients With Type 2 Diabetes: A Call to Action. 2型糖尿病患者围手术期护理的数字化决策支持:行动呼吁
Q2 Medicine Pub Date : 2025-04-08 DOI: 10.2196/70475
Jianwen Cai, Peiyi Li, Weimin Li, Xuechao Hao, Sheyu Li, Tao Zhu

Unlabelled: Type 2 diabetes mellitus affects over 500 million people globally, with 10%-20% requiring surgery. Patients with diabetes are at increased risk for perioperative complications, including prolonged hospital stays and higher mortality, primarily due to perioperative hyperglycemia. Managing blood glucose during the perioperative period is challenging, and conventional monitoring is often inadequate to detect rapid fluctuations. Clinical decision support systems (CDSS) are emerging tools to improve perioperative diabetes management by providing real-time glucose data and medication recommendations. This viewpoint examines the role of CDSS in perioperative diabetes care, highlighting their benefits and limitations. CDSS can help manage blood glucose more effectively, preventing both hyperglycemia and hypoglycemia. However, technical and integration challenges, along with clinician acceptance, remain significant barriers.

未标示:2型糖尿病影响全球超过5亿人,其中10%-20%需要手术治疗。糖尿病患者围手术期并发症的风险增加,包括住院时间延长和死亡率升高,主要是由于围手术期高血糖。围手术期血糖管理具有挑战性,常规监测往往不足以检测快速波动。临床决策支持系统(CDSS)是通过提供实时血糖数据和药物建议来改善围手术期糖尿病管理的新兴工具。这一观点探讨了CDSS在围手术期糖尿病护理中的作用,强调了它们的优点和局限性。CDSS可以帮助更有效地控制血糖,预防高血糖和低血糖。然而,技术和集成方面的挑战,以及临床医生的接受程度,仍然是重大障碍。
{"title":"Digital Decision Support for Perioperative Care of Patients With Type 2 Diabetes: A Call to Action.","authors":"Jianwen Cai, Peiyi Li, Weimin Li, Xuechao Hao, Sheyu Li, Tao Zhu","doi":"10.2196/70475","DOIUrl":"10.2196/70475","url":null,"abstract":"<p><strong>Unlabelled: </strong>Type 2 diabetes mellitus affects over 500 million people globally, with 10%-20% requiring surgery. Patients with diabetes are at increased risk for perioperative complications, including prolonged hospital stays and higher mortality, primarily due to perioperative hyperglycemia. Managing blood glucose during the perioperative period is challenging, and conventional monitoring is often inadequate to detect rapid fluctuations. Clinical decision support systems (CDSS) are emerging tools to improve perioperative diabetes management by providing real-time glucose data and medication recommendations. This viewpoint examines the role of CDSS in perioperative diabetes care, highlighting their benefits and limitations. CDSS can help manage blood glucose more effectively, preventing both hyperglycemia and hypoglycemia. However, technical and integration challenges, along with clinician acceptance, remain significant barriers.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e70475"},"PeriodicalIF":0.0,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11999379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
eHealth Literacy and Its Association With Demographic Factors, Disease-Specific Factors, and Well-Being Among Adults With Type 1 Diabetes: Cross-Sectional Survey Study. 1型糖尿病成人的电子健康素养及其与人口统计学因素、疾病特异性因素和幸福感的关系:横断面调查研究
Q2 Medicine Pub Date : 2025-03-31 DOI: 10.2196/66117
Divya Anna Stephen, Anna Nordin, Unn-Britt Johansson, Jan Nilsson
<p><strong>Background: </strong>The use of digital health technology in diabetes self-care is increasing, making eHealth literacy an important factor to consider among people with type 1 diabetes. There are very few studies investigating eHealth literacy among adults with type 1 diabetes, highlighting the need to explore this area further.</p><p><strong>Objective: </strong>The aim of this study was to explore associations between eHealth literacy and demographic factors, disease-specific factors, and well-being among adults with type 1 diabetes.</p><p><strong>Methods: </strong>The study used data from a larger cross-sectional survey conducted among adults with type 1 diabetes in Sweden (N=301). Participants were recruited using a convenience sampling method primarily through advertisements on social media. Data were collected between September and November 2022 primarily through a web-based survey, although participants could opt to answer a paper-based survey. Screening questions at the beginning of the survey determined eligibility to participate. In this study, eHealth literacy was assessed using the Swedish version of the eHealth Literacy Scale (Sw-eHEALS). The predictor variables, well-being was assessed using the World Health Organization-5 Well-Being Index and psychosocial self-efficacy using the Swedish version of the Diabetes Empowerment Scale. The survey also included research group-developed questions on demographic and disease-specific variables as well as digital health technology use. Data were analyzed using multiple linear regression presented as nested models. A sample size of 270 participants was required in order to detect an association between the dependent and predictor variables using a regression model based on an F test. The final sample size included in the nested regression model was 285.</p><p><strong>Results: </strong>The mean Sw-eHEALS score was 33.42 (SD 5.32; range 8-40). The model involving both demographic and disease-specific variables explained 31.5% of the total variation in eHealth literacy and was deemed the best-fitting model. Younger age (P=.01; B=-0.07, SE=0.03;95% CI -0.12 to -0.02), lower self-reported glycated hemoglobin levels (P=.04; B=-0.06, SE=0.03; 95% CI -0.12 to 0.00), and higher psychosocial self-efficacy (P<.001; B=3.72, SE=0.53; 95% CI 2.68-4.75) were found associated with higher Sw-eHEALS scores when adjusted for demographic and disease-specific variables in this model. Well-being was not associated with eHealth literacy in this study.</p><p><strong>Conclusions: </strong>The demographic and disease-specific factors explained the variation in eHealth literacy in this sample. Further studies in this area using newer eHealth literacy tools are important to validate our findings. The study highlights the importance of development and testing of interventions to improve eHealth literacy in this population for better glucose control. These eHealth literacy interventions should be tailored to meet
背景:数字健康技术在糖尿病自我保健中的应用越来越多,使得电子健康素养成为1型糖尿病患者需要考虑的一个重要因素。很少有研究调查1型糖尿病成年人的电子健康素养,这突出了进一步探索这一领域的必要性。目的:本研究的目的是探讨电子健康素养与1型糖尿病成年人的人口统计学因素、疾病特异性因素和幸福感之间的关系。方法:该研究使用了来自瑞典1型糖尿病成人(N=301)的更大的横断面调查数据。参与者主要通过社交媒体上的广告采用方便的抽样方法招募。数据在2022年9月至11月期间主要通过网络调查收集,尽管参与者可以选择回答纸质调查。调查开始时的筛选问题决定了参与的资格。在这项研究中,使用瑞典版的电子健康素养量表(Sw-eHEALS)评估了电子健康素养。预测变量,幸福感是使用世界卫生组织5幸福指数和社会心理自我效能评估使用瑞典版糖尿病授权量表。该调查还包括研究小组提出的关于人口统计和疾病特定变量以及数字卫生技术使用的问题。数据分析采用多元线性回归呈现为嵌套模型。为了使用基于F检验的回归模型来检测因变量和预测变量之间的关联,需要270名参与者的样本量。嵌套回归模型的最终样本量为285。结果:Sw-eHEALS平均评分为33.42分(SD 5.32;范围8-40)。该模型涉及人口统计学和疾病特异性变量,解释了电子健康素养总变异的31.5%,被认为是最合适的模型。年龄较小(P= 0.01;B=-0.07, SE=0.03;95% CI -0.12 ~ -0.02),较低的自我报告糖化血红蛋白水平(P= 0.04;B = -0.06, SE = 0.03;95% CI -0.12至0.00),以及更高的社会心理自我效能(结论:人口统计学和疾病特异性因素解释了该样本中电子健康素养的差异。在这一领域使用更新的电子健康素养工具的进一步研究对于验证我们的发现很重要。该研究强调了开发和测试干预措施的重要性,以提高这一人群的电子健康素养,从而更好地控制血糖。这些电子卫生扫盲干预措施应量身定制,以满足不同年龄组和不同心理社会自我效能水平人群的需求。
{"title":"eHealth Literacy and Its Association With Demographic Factors, Disease-Specific Factors, and Well-Being Among Adults With Type 1 Diabetes: Cross-Sectional Survey Study.","authors":"Divya Anna Stephen, Anna Nordin, Unn-Britt Johansson, Jan Nilsson","doi":"10.2196/66117","DOIUrl":"10.2196/66117","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The use of digital health technology in diabetes self-care is increasing, making eHealth literacy an important factor to consider among people with type 1 diabetes. There are very few studies investigating eHealth literacy among adults with type 1 diabetes, highlighting the need to explore this area further.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The aim of this study was to explore associations between eHealth literacy and demographic factors, disease-specific factors, and well-being among adults with type 1 diabetes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The study used data from a larger cross-sectional survey conducted among adults with type 1 diabetes in Sweden (N=301). Participants were recruited using a convenience sampling method primarily through advertisements on social media. Data were collected between September and November 2022 primarily through a web-based survey, although participants could opt to answer a paper-based survey. Screening questions at the beginning of the survey determined eligibility to participate. In this study, eHealth literacy was assessed using the Swedish version of the eHealth Literacy Scale (Sw-eHEALS). The predictor variables, well-being was assessed using the World Health Organization-5 Well-Being Index and psychosocial self-efficacy using the Swedish version of the Diabetes Empowerment Scale. The survey also included research group-developed questions on demographic and disease-specific variables as well as digital health technology use. Data were analyzed using multiple linear regression presented as nested models. A sample size of 270 participants was required in order to detect an association between the dependent and predictor variables using a regression model based on an F test. The final sample size included in the nested regression model was 285.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The mean Sw-eHEALS score was 33.42 (SD 5.32; range 8-40). The model involving both demographic and disease-specific variables explained 31.5% of the total variation in eHealth literacy and was deemed the best-fitting model. Younger age (P=.01; B=-0.07, SE=0.03;95% CI -0.12 to -0.02), lower self-reported glycated hemoglobin levels (P=.04; B=-0.06, SE=0.03; 95% CI -0.12 to 0.00), and higher psychosocial self-efficacy (P&lt;.001; B=3.72, SE=0.53; 95% CI 2.68-4.75) were found associated with higher Sw-eHEALS scores when adjusted for demographic and disease-specific variables in this model. Well-being was not associated with eHealth literacy in this study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The demographic and disease-specific factors explained the variation in eHealth literacy in this sample. Further studies in this area using newer eHealth literacy tools are important to validate our findings. The study highlights the importance of development and testing of interventions to improve eHealth literacy in this population for better glucose control. These eHealth literacy interventions should be tailored to meet ","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e66117"},"PeriodicalIF":0.0,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11975121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of AI in Predicting Drug Responses for Type 2 Diabetes. 人工智能在预测2型糖尿病药物反应中的应用
Q2 Medicine Pub Date : 2025-03-27 DOI: 10.2196/66831
Shilpa Garg, Robert Kitchen, Ramneek Gupta, Ewan Pearson

Unlabelled: Type 2 diabetes mellitus has seen a continuous rise in prevalence in recent years, and a similar trend has been observed in the increased availability of glucose-lowering drugs. There is a need to understand the variation in treatment response to these drugs to be able to predict people who will respond well or poorly to a drug. Electronic health records, clinical trials, and observational studies provide a huge amount of data to explore predictors of drug response. The use of artificial intelligence (AI), which includes machine learning and deep learning techniques, has the capacity to improve the prediction of treatment response in patients. AI can assist in the analysis of vast datasets to identify patterns and may provide valuable information on selecting an effective drug. Predicting an individual's response to a drug can aid in treatment selection, optimizing therapy, exploring new therapeutic options, and personalized medicine. This viewpoint highlights the growing evidence supporting the potential of AI-based methods to predict drug response with accuracy. Furthermore, the methods highlight a trend toward using ensemble methods as preferred models in drug response prediction studies.

未标记:近年来,2型糖尿病的患病率持续上升,并且在降糖药物的可用性增加中也观察到类似的趋势。有必要了解对这些药物的治疗反应的变化,以便能够预测人们对药物的反应是好是坏。电子健康记录、临床试验和观察性研究为探索药物反应的预测因素提供了大量数据。人工智能(AI)的使用,包括机器学习和深度学习技术,有能力改善对患者治疗反应的预测。人工智能可以协助分析大量数据集以确定模式,并可能提供选择有效药物的有价值信息。预测个体对药物的反应有助于治疗选择、优化治疗、探索新的治疗方案和个性化治疗。这一观点强调了越来越多的证据支持基于人工智能的方法在准确预测药物反应方面的潜力。此外,这些方法强调了在药物反应预测研究中使用集成方法作为首选模型的趋势。
{"title":"Applications of AI in Predicting Drug Responses for Type 2 Diabetes.","authors":"Shilpa Garg, Robert Kitchen, Ramneek Gupta, Ewan Pearson","doi":"10.2196/66831","DOIUrl":"10.2196/66831","url":null,"abstract":"<p><strong>Unlabelled: </strong>Type 2 diabetes mellitus has seen a continuous rise in prevalence in recent years, and a similar trend has been observed in the increased availability of glucose-lowering drugs. There is a need to understand the variation in treatment response to these drugs to be able to predict people who will respond well or poorly to a drug. Electronic health records, clinical trials, and observational studies provide a huge amount of data to explore predictors of drug response. The use of artificial intelligence (AI), which includes machine learning and deep learning techniques, has the capacity to improve the prediction of treatment response in patients. AI can assist in the analysis of vast datasets to identify patterns and may provide valuable information on selecting an effective drug. Predicting an individual's response to a drug can aid in treatment selection, optimizing therapy, exploring new therapeutic options, and personalized medicine. This viewpoint highlights the growing evidence supporting the potential of AI-based methods to predict drug response with accuracy. Furthermore, the methods highlight a trend toward using ensemble methods as preferred models in drug response prediction studies.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e66831"},"PeriodicalIF":0.0,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes: Development and Usability Study of a Virtual Intervention With Multisystem Community Partners. 针对小儿 1 型糖尿病的学校协作护理 (SPACE):与多系统社区合作伙伴开展虚拟干预的开发和可用性研究。
Q2 Medicine Pub Date : 2025-03-26 DOI: 10.2196/64096
Christine A March, Elissa Naame, Ingrid Libman, Chelsea N Proulx, Linda Siminerio, Elizabeth Miller, Aaron R Lyon

Background: School-partnered interventions may improve health outcomes for children with type 1 diabetes, though there is limited evidence to support their effectiveness and sustainability. Family, school, or health system factors may interfere with intervention usability and implementation.

Objective: To identify and address potential implementation barriers during intervention development, we combined methods in user-centered design and implementation science to adapt an evidence-based psychosocial intervention, the collaborative care model, to a virtual school-partnered collaborative care (SPACE) model for type 1 diabetes between schools and diabetes medical teams.

Methods: We recruited patient, family, school, and health system partners (n=20) to cocreate SPACE through iterative, web-based design sessions using a digital whiteboard (phase 1). User-centered design methods included independent and group activities for idea generation, visual voting, and structured critique of the evolving SPACE prototype. In phase 2, the prototype was evaluated with the usability evaluation for evidence-based psychosocial interventions methods. School nurses reviewed the prototype and tasks in cognitive walkthroughs and completed the Intervention Usability Scale (IUS). Two members of the research team independently identified and prioritized (1-3 rating) discrete usability concerns. We evaluated the relationship between prioritization and the percentage of nurses reporting each usability issue with Spearman correlation. Differences in IUS scores by school nurse characteristics were assessed with ANOVA.

Results: In the design phase, the partners generated over 90 unique ideas for SPACE, prioritizing elements pertaining to intervention adaptability, team-based communication, and multidimensional outcome tracking. Following three iterations of prototype development, cognitive walkthroughs were completed with 10 school nurses (n=10, 100% female; mean age 48.5, SD 9.5 years) representing different districts and years of experience. Nurses identified 16 discrete usability issues (each reported by 10%-60% of participants). Two issues receiving the highest priority (3.0): ability to access a virtual platform (n=3, 30% of participants) and data-sharing mechanisms between nurses and providers (n=6, 60% of participants). There was a moderate correlation between priority rating and the percentage of nurses reporting each issue (ρ=0.63; P=.01). Average IUS ratings (77.8, SD 11.1; 100-point scale) indicated appropriate usability. There was no difference in IUS ratings by school nurse experience (P=.54), student caseload (P=.12), number of schools covered (P=.90), or prior experience with type 1 diabetes (P=.83), suggesting that other factors may influence usability. The design team recommended strategies for SPACE implementation to overcome high-priority issues, including training users

背景:学校合作干预可能改善1型糖尿病儿童的健康结果,尽管支持其有效性和可持续性的证据有限。家庭、学校或卫生系统因素可能会干扰干预措施的可用性和实施。目的:为了识别和解决干预开发过程中潜在的实施障碍,我们结合了以用户为中心的设计和实施科学的方法,将基于证据的社会心理干预,即协作护理模式,应用于学校和糖尿病医疗团队之间的1型糖尿病虚拟学校伙伴协作护理(SPACE)模式。方法:我们招募了患者、家庭、学校和卫生系统的合作伙伴(n=20),通过使用数字白板的迭代、基于网络的设计会议(阶段1)共同创建SPACE。以用户为中心的设计方法包括独立和小组活动,以产生想法、视觉投票和对不断发展的SPACE原型进行结构化批评。在第二阶段,对原型进行了基于证据的社会心理干预方法可用性评估。学校护士对认知演练中的原型和任务进行了回顾,并完成了干预可用性量表(IUS)。研究团队的两名成员独立地确定和优先级(1-3级)离散的可用性关注点。我们用Spearman相关性评估了优先级和报告每个可用性问题的护士百分比之间的关系。采用方差分析评估学校护士特征的IUS评分差异。结果:在设计阶段,合作伙伴为SPACE产生了90多个独特的想法,优先考虑了干预适应性、团队沟通和多维结果跟踪等因素。经过三次原型开发迭代,10名学校护士(n=10, 100%为女性;平均年龄48.5岁,标准差9.5岁),代表不同的地区和经验。护士确定了16个独立的可用性问题(每个问题由10%-60%的参与者报告)。获得最高优先级(3.0)的两个问题:访问虚拟平台的能力(n= 3,30%的参与者)和护士和提供者之间的数据共享机制(n= 6,60%的参与者)。优先级与报告每个问题的护士百分比之间存在中等相关性(ρ=0.63;P = . 01)。平均IUS评分(77.8,SD 11.1;100分制)表示适当的可用性。学校护士经验(P= 0.54)、学生病例量(P= 0.12)、覆盖的学校数量(P= 0.90)或先前患1型糖尿病的经历(P= 0.83)对IUS评分没有差异,这表明其他因素可能影响可用性。设计团队为SPACE的实施提出了克服高优先级问题的策略,包括培训用户使用视频会议应用程序,建立安全的学校数据报告表格,以及在SPACE会议期间实时共享葡萄糖数据。结论:跨部门干预是复杂的,感知可用性是实施的潜在障碍。与社区合作伙伴一起使用基于网络的共同创造方法,促进了与最终用户优先事项一致的高质量干预设计。定量和定性评估表明了适当程度的可用性,以便进行试点测试。
{"title":"School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes: Development and Usability Study of a Virtual Intervention With Multisystem Community Partners.","authors":"Christine A March, Elissa Naame, Ingrid Libman, Chelsea N Proulx, Linda Siminerio, Elizabeth Miller, Aaron R Lyon","doi":"10.2196/64096","DOIUrl":"10.2196/64096","url":null,"abstract":"<p><strong>Background: </strong>School-partnered interventions may improve health outcomes for children with type 1 diabetes, though there is limited evidence to support their effectiveness and sustainability. Family, school, or health system factors may interfere with intervention usability and implementation.</p><p><strong>Objective: </strong>To identify and address potential implementation barriers during intervention development, we combined methods in user-centered design and implementation science to adapt an evidence-based psychosocial intervention, the collaborative care model, to a virtual school-partnered collaborative care (SPACE) model for type 1 diabetes between schools and diabetes medical teams.</p><p><strong>Methods: </strong>We recruited patient, family, school, and health system partners (n=20) to cocreate SPACE through iterative, web-based design sessions using a digital whiteboard (phase 1). User-centered design methods included independent and group activities for idea generation, visual voting, and structured critique of the evolving SPACE prototype. In phase 2, the prototype was evaluated with the usability evaluation for evidence-based psychosocial interventions methods. School nurses reviewed the prototype and tasks in cognitive walkthroughs and completed the Intervention Usability Scale (IUS). Two members of the research team independently identified and prioritized (1-3 rating) discrete usability concerns. We evaluated the relationship between prioritization and the percentage of nurses reporting each usability issue with Spearman correlation. Differences in IUS scores by school nurse characteristics were assessed with ANOVA.</p><p><strong>Results: </strong>In the design phase, the partners generated over 90 unique ideas for SPACE, prioritizing elements pertaining to intervention adaptability, team-based communication, and multidimensional outcome tracking. Following three iterations of prototype development, cognitive walkthroughs were completed with 10 school nurses (n=10, 100% female; mean age 48.5, SD 9.5 years) representing different districts and years of experience. Nurses identified 16 discrete usability issues (each reported by 10%-60% of participants). Two issues receiving the highest priority (3.0): ability to access a virtual platform (n=3, 30% of participants) and data-sharing mechanisms between nurses and providers (n=6, 60% of participants). There was a moderate correlation between priority rating and the percentage of nurses reporting each issue (ρ=0.63; P=.01). Average IUS ratings (77.8, SD 11.1; 100-point scale) indicated appropriate usability. There was no difference in IUS ratings by school nurse experience (P=.54), student caseload (P=.12), number of schools covered (P=.90), or prior experience with type 1 diabetes (P=.83), suggesting that other factors may influence usability. The design team recommended strategies for SPACE implementation to overcome high-priority issues, including training users ","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e64096"},"PeriodicalIF":0.0,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11982762/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining How Adults With Diabetes Use Technologies to Support Diabetes Self-Management: Mixed Methods Study. 检查成人糖尿病患者如何使用技术支持糖尿病自我管理:混合方法研究。
Q2 Medicine Pub Date : 2025-03-25 DOI: 10.2196/64505
Timothy Bober, Sophia Garvin, Jodi Krall, Margaret Zupa, Carissa Low, Ann-Marie Rosland
<p><strong>Background: </strong>Technologies such as mobile apps, continuous glucose monitors (CGMs), and activity trackers are available to support adults with diabetes, but it is not clear how they are used together for diabetes self-management.</p><p><strong>Objective: </strong>This study aims to understand how adults with diabetes with differing clinical profiles and digital health literacy levels integrate data from multiple behavior tracking technologies for diabetes self-management.</p><p><strong>Methods: </strong>Adults with type 1 or 2 diabetes who used ≥1 diabetes medications responded to a web-based survey about health app and activity tracker use in 6 categories: blood glucose level, diet, exercise and activity, weight, sleep, and stress. Digital health literacy was assessed using the Digital Health Care Literacy Scale, and general health literacy was assessed using the Brief Health Literacy Screen. We analyzed descriptive statistics among respondents and compared health technology use using independent 2-tailed t tests for continuous variables, chi-square for categorical variables, and Fisher exact tests for digital health literacy levels. Semistructured interviews examined how these technologies were and could be used to support daily diabetes self-management. We summarized interview themes using content analysis.</p><p><strong>Results: </strong>Of the 61 survey respondents, 21 (34%) were Black, 23 (38%) were female, and 29 (48%) were aged ≥45 years; moreover, 44 (72%) had type 2 diabetes, 36 (59%) used insulin, and 34 (56%) currently or previously used a CGM. Respondents had high levels of digital and general health literacy: 87% (46/53) used at least 1 health app, 59% (36/61) had used an activity tracker, and 62% (33/53) used apps to track ≥1 health behaviors. CGM users and nonusers used non-CGM health apps at similar rates (16/28, 57% vs 12/20, 60%; P=.84). Activity tracker use was also similar between CGM users and nonusers (20/33, 61% vs 14/22, 64%; P=.82). Respondents reported sharing self-monitor data with health care providers at similar rates across age groups (17/32, 53% for those aged 18-44 y vs 16/29, 55% for those aged 45-70 y; P=.87). Combined activity tracker and health app use was higher among those with higher Digital Health Care Literacy Scale scores, but this difference was not statistically significant (P=.09). Interviewees (18/61, 30%) described using blood glucose level tracking apps to personalize dietary choices but less frequently used data from apps or activity trackers to meet other self-management goals. Interviewees desired data that were passively collected, easily integrated across data sources, visually presented, and tailorable to self-management priorities.</p><p><strong>Conclusions: </strong>Adults with diabetes commonly used apps and activity trackers, often alongside CGMs, to track multiple behaviors that impact diabetes self-management but found it challenging to link tracked behaviors to glycem
背景:移动应用程序、连续血糖监测仪(CGM)和活动追踪器等技术可为成年糖尿病患者提供支持,但目前尚不清楚如何将这些技术用于糖尿病自我管理:本研究旨在了解具有不同临床特征和数字健康知识水平的成人糖尿病患者如何整合来自多种行为追踪技术的数据进行糖尿病自我管理:使用≥1种糖尿病药物的1型或2型糖尿病成人接受了一项基于网络的调查,内容涉及血糖水平、饮食、运动和活动、体重、睡眠和压力等6类健康应用程序和活动追踪器的使用情况。数字健康素养采用数字健康护理素养量表进行评估,一般健康素养采用简要健康素养筛查进行评估。我们对受访者进行了描述性统计分析,并使用独立的双尾 t 检验(连续变量)、卡方检验(分类变量)和费雪精确检验(数字健康素养水平)比较了健康技术的使用情况。半结构式访谈考察了这些技术是如何以及可以如何用于支持日常糖尿病自我管理的。我们使用内容分析法总结了访谈主题:在 61 名调查对象中,21 人(34%)为黑人,23 人(38%)为女性,29 人(48%)年龄≥45 岁;此外,44 人(72%)患有 2 型糖尿病,36 人(59%)使用胰岛素,34 人(56%)目前或以前使用过 CGM。受访者具有较高的数字和一般健康知识水平:87%(46/53)的受访者至少使用过一种健康应用程序,59%(36/61)的受访者使用过活动追踪器,62%(33/53)的受访者使用应用程序追踪≥一种健康行为。CGM 用户和非用户使用非 CGM 健康应用程序的比例相似(16/28,57% vs 12/20,60%;P=.84)。CGM 用户和非用户使用活动追踪器的情况也相似(20/33,61% vs 14/22,64%;P=.82)。不同年龄组的受访者报告与医疗服务提供者共享自我监测数据的比例相似(18-44 岁的受访者为 17/32,53%;45-70 岁的受访者为 16/29,55%;P=.87)。在数字保健素养量表得分较高的受访者中,活动追踪器和健康应用程序的综合使用率较高,但这一差异并无统计学意义(P=.09)。受访者(18/61,30%)描述了使用血糖水平追踪应用程序来个性化饮食选择的情况,但较少使用应用程序或活动追踪器的数据来实现其他自我管理目标。受访者希望数据是被动收集的,易于跨数据源整合,可视化呈现,并适合自我管理的优先事项:成人糖尿病患者通常使用应用程序和活动追踪器(通常与血糖监测仪一起使用)来追踪影响糖尿病自我管理的多种行为,但他们发现将所追踪的行为与血糖和糖尿病自我管理目标联系起来具有挑战性。研究结果表明,在整合应用程序和活动追踪器的数据以支持以患者为中心的糖尿病自我管理方面还存在尚未开发的机会。
{"title":"Examining How Adults With Diabetes Use Technologies to Support Diabetes Self-Management: Mixed Methods Study.","authors":"Timothy Bober, Sophia Garvin, Jodi Krall, Margaret Zupa, Carissa Low, Ann-Marie Rosland","doi":"10.2196/64505","DOIUrl":"10.2196/64505","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Technologies such as mobile apps, continuous glucose monitors (CGMs), and activity trackers are available to support adults with diabetes, but it is not clear how they are used together for diabetes self-management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to understand how adults with diabetes with differing clinical profiles and digital health literacy levels integrate data from multiple behavior tracking technologies for diabetes self-management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Adults with type 1 or 2 diabetes who used ≥1 diabetes medications responded to a web-based survey about health app and activity tracker use in 6 categories: blood glucose level, diet, exercise and activity, weight, sleep, and stress. Digital health literacy was assessed using the Digital Health Care Literacy Scale, and general health literacy was assessed using the Brief Health Literacy Screen. We analyzed descriptive statistics among respondents and compared health technology use using independent 2-tailed t tests for continuous variables, chi-square for categorical variables, and Fisher exact tests for digital health literacy levels. Semistructured interviews examined how these technologies were and could be used to support daily diabetes self-management. We summarized interview themes using content analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 61 survey respondents, 21 (34%) were Black, 23 (38%) were female, and 29 (48%) were aged ≥45 years; moreover, 44 (72%) had type 2 diabetes, 36 (59%) used insulin, and 34 (56%) currently or previously used a CGM. Respondents had high levels of digital and general health literacy: 87% (46/53) used at least 1 health app, 59% (36/61) had used an activity tracker, and 62% (33/53) used apps to track ≥1 health behaviors. CGM users and nonusers used non-CGM health apps at similar rates (16/28, 57% vs 12/20, 60%; P=.84). Activity tracker use was also similar between CGM users and nonusers (20/33, 61% vs 14/22, 64%; P=.82). Respondents reported sharing self-monitor data with health care providers at similar rates across age groups (17/32, 53% for those aged 18-44 y vs 16/29, 55% for those aged 45-70 y; P=.87). Combined activity tracker and health app use was higher among those with higher Digital Health Care Literacy Scale scores, but this difference was not statistically significant (P=.09). Interviewees (18/61, 30%) described using blood glucose level tracking apps to personalize dietary choices but less frequently used data from apps or activity trackers to meet other self-management goals. Interviewees desired data that were passively collected, easily integrated across data sources, visually presented, and tailorable to self-management priorities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Adults with diabetes commonly used apps and activity trackers, often alongside CGMs, to track multiple behaviors that impact diabetes self-management but found it challenging to link tracked behaviors to glycem","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e64505"},"PeriodicalIF":0.0,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11979526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1